Successful candidates will engage in research in the area of Immuno-Oncology
Selected projects in the area of Immuno-Oncology may use in vitro, in vivo and in silico models to investigate current issues, such as:
- Targeting and mathematical modelling of RTK and GPCR systems in immune-oncology and checkpoint blockade
- Nanobody targeting of chemokine receptors
- Molecular pharmacology of tumour microenvironment
- Gene editing in immuno-oncology
- Advanced 3D in vitro modelling tumour-immune interactions
- Adaptive immune activation of tumour growth
- Hypoxia and innate immune activation
- HER2 and immunotherapy in breast cancer